| Welcome and Report from the
Chairman |
Dr. Claude Lenfant |
| Results of Recent Trials:
HPS, PROSPER, and ASCOT* |
Dr. David Gordon |
| Proposed NCEP Paper on Four
Trials in Relation to ATP III Guidelines: HPS, PROSPER, ASCOT, and ALLHAT* |
Dr. Scott Grundy |
| Approval of Ezetimibe: A New
Class of Cholesterol-Lowering Drugs |
Dr. James McKenney |
| Coordinator's Report |
Dr. James Cleeman |
| BREAK |
|
| Reducing Lifetime Risk for
Coronary Heart Disease (CHD): Report on Think Tank Meeting to Discuss a
Proposed "Know Your Numbers" Outreach Program |
Dr. Lenfant |
| Comments from Think Tank
Participants and Coordinating Committee Discussion of the Proposed "Know Your
Numbers" Outreach Program |
|
LUNCH
Small Group
Discussions: Proposed "Know Your Numbers" Outreach Program |
|
| Reports from the Small Group
Discussions |
|
| Open Forum: Comments from
Invited Guests |
|
| Adjournment |
|
